LFG
ATYR

Larson Financial Group’s aTyr Pharma ATYR Stock Holding History

Larson Financial Group’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90 Hold
150
– – ﹤0.01% 3659
2026
Q1 		$117 Hold
150
– – ﹤0.01% 3508
2025
Q4 		$117 Hold
150
– – ﹤0.01% 3324
2025
Q3 		$108 Buy
+150
New +$680 ﹤0.01% 3320

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Larson Financial Group's ATYR Position: Q2 2026 in Review

Larson Financial Group held its aTyr Pharma (ATYR) position steady in Q2 2026 at 150 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #3659.

Larson Financial Group first reported a position in ATYR in Q3 2025 and has held it in 4 quarters since. The position peaked at $117 in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Larson Financial Group held 150 shares of aTyr Pharma worth $90 as of Q2 2026.
  • Larson Financial Group left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3659 holding.
  • Larson Financial Group first reported a position in aTyr Pharma in Q3 2025 and has held it in 4 quarters since.
  • Larson Financial Group's aTyr Pharma position peaked at $117 in Q1 2026.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.